ZA200108718B - Thiazolidinedione derivative and its use as antidiabetic. - Google Patents

Thiazolidinedione derivative and its use as antidiabetic.

Info

Publication number
ZA200108718B
ZA200108718B ZA200108718A ZA200108718A ZA200108718B ZA 200108718 B ZA200108718 B ZA 200108718B ZA 200108718 A ZA200108718 A ZA 200108718A ZA 200108718 A ZA200108718 A ZA 200108718A ZA 200108718 B ZA200108718 B ZA 200108718B
Authority
ZA
South Africa
Prior art keywords
antidiabetic
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
ZA200108718A
Other languages
English (en)
Inventor
Blackler Paul David James
Giles Robert Gordon
Stephen Moore
Sasse Michael John
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909471.6A external-priority patent/GB9909471D0/en
Priority claimed from GBGB9912195.6A external-priority patent/GB9912195D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA200108718B publication Critical patent/ZA200108718B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
ZA200108718A 1999-04-23 2001-10-23 Thiazolidinedione derivative and its use as antidiabetic. ZA200108718B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909471.6A GB9909471D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912195.6A GB9912195D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical
PCT/GB2000/001522 WO2000064893A2 (fr) 1999-04-23 2000-04-19 Nouvel agent pharmaceutique

Publications (1)

Publication Number Publication Date
ZA200108718B true ZA200108718B (en) 2002-12-03

Family

ID=26315459

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108718A ZA200108718B (en) 1999-04-23 2001-10-23 Thiazolidinedione derivative and its use as antidiabetic.

Country Status (36)

Country Link
EP (2) EP1277753A1 (fr)
JP (1) JP2002543076A (fr)
KR (1) KR100744361B1 (fr)
CN (1) CN1152878C (fr)
AP (1) AP1607A (fr)
AR (2) AR023750A1 (fr)
AU (2) AU4307200A (fr)
BG (1) BG65517B1 (fr)
BR (1) BR0009935A (fr)
CA (1) CA2370262A1 (fr)
CO (1) CO5170419A1 (fr)
CZ (1) CZ20013801A3 (fr)
DZ (1) DZ3164A1 (fr)
EA (1) EA003031B1 (fr)
EG (1) EG23937A (fr)
GC (1) GC0000250A (fr)
HK (1) HK1045152A1 (fr)
HR (1) HRP20010774A2 (fr)
HU (1) HUP0200937A3 (fr)
IL (1) IL146115A0 (fr)
MA (1) MA26786A1 (fr)
MX (1) MXPA01010822A (fr)
MY (1) MY138673A (fr)
NO (1) NO320587B1 (fr)
NZ (1) NZ515167A (fr)
OA (1) OA11873A (fr)
PE (1) PE20010045A1 (fr)
PL (1) PL351685A1 (fr)
SK (1) SK14932001A3 (fr)
TR (1) TR200103060T2 (fr)
TW (1) TWI288749B (fr)
UA (1) UA67845C2 (fr)
UY (1) UY26119A1 (fr)
WO (1) WO2000064893A2 (fr)
YU (1) YU75401A (fr)
ZA (1) ZA200108718B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
IL145796A0 (en) * 1999-04-13 2002-07-25 Us Health Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
EP1173435B1 (fr) 1999-04-23 2003-07-30 SmithKline Beecham plc Nouvelle forme polymorphe du sel d'acide 5- 4- 2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione,maleique
TR200103061T2 (tr) 1999-04-23 2002-05-21 Smithkline Beecham P.L.C. Yeni farmasötik madde.
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US7241895B2 (en) * 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
WO2004062667A1 (fr) * 2003-01-08 2004-07-29 Dr. Reddy's Laboratories Limited Forme amorphe du maleate de rosiglitazone et procede de preparation
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (fr) * 2003-04-18 2004-11-03 CHEMI S.p.A. Formes polymorphes de maléate de rosiglitatone
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
TW201336497A (zh) * 2007-02-08 2013-09-16 Daiichi Sankyo Co Ltd 噻唑啶二酮化合物之結晶型及其製法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
TR200103060T2 (tr) 2002-05-21
HUP0200937A2 (en) 2002-08-28
EG23937A (en) 2008-01-14
KR100744361B1 (ko) 2007-07-30
IL146115A0 (en) 2002-07-25
NZ515167A (en) 2004-02-27
AU2755102A (en) 2002-05-16
NO20015148L (no) 2001-12-17
CN1152878C (zh) 2004-06-09
WO2000064893A3 (fr) 2001-01-25
CZ20013801A3 (cs) 2002-07-17
AP2001002329A0 (en) 2001-12-31
CN1355800A (zh) 2002-06-26
HRP20010774A2 (en) 2002-10-31
AR023750A1 (es) 2002-09-04
PE20010045A1 (es) 2001-03-10
BG106122A (en) 2002-05-31
MXPA01010822A (es) 2002-06-04
AR023560A1 (es) 2002-09-04
CO5170419A1 (es) 2002-06-27
AP1607A (en) 2006-05-03
AU771342B2 (en) 2004-03-18
EP1277753A1 (fr) 2003-01-22
UA67845C2 (uk) 2004-07-15
AU4307200A (en) 2000-11-10
YU75401A (sh) 2004-09-03
BG65517B1 (bg) 2008-10-31
SK14932001A3 (sk) 2002-02-05
KR20010110804A (ko) 2001-12-13
EA003031B1 (ru) 2002-12-26
PL351685A1 (en) 2003-06-02
DZ3164A1 (fr) 2000-11-02
OA11873A (en) 2006-03-27
UY26119A1 (es) 2000-12-29
WO2000064893A2 (fr) 2000-11-02
HUP0200937A3 (en) 2004-03-29
TWI288749B (en) 2007-10-21
JP2002543076A (ja) 2002-12-17
MA26786A1 (fr) 2004-12-20
NO320587B1 (no) 2005-12-27
CA2370262A1 (fr) 2000-11-02
EA200101122A1 (ru) 2002-04-25
BR0009935A (pt) 2002-04-16
HK1045152A1 (zh) 2002-11-15
EP1175418A2 (fr) 2002-01-30
MY138673A (en) 2009-07-31
GC0000250A (en) 2006-11-01
NO20015148D0 (no) 2001-10-22

Similar Documents

Publication Publication Date Title
HK1047743A1 (en) New use and novel n-azabicyclo-amide derivatives.
ZA200204283B (en) Novel antidiabetic agents.
ZA200203367B (en) Antidiabetic formulation and method.
HRP20020375A2 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
HK1045154A1 (en) Thiazolidinedione derivative and its use as antidiabetic
ZA200108718B (en) Thiazolidinedione derivative and its use as antidiabetic.
EP1210084A4 (fr) Pyridomorphinanes, thienomorphinanes et utilisation
MXPA02005011A (es) Nuevos derivados de tiazolidindiona como agentes antidiabeticos.
HK1045151A1 (en) Thiazolidinedione derivative and its use as antidiabetic.
HK1045304A1 (en) Thiazolidinedione derivative and its use as antidiabetic.
GB9917593D0 (en) Compound, composition, process and use
AU1857701A (en) Benzoxa- and benzthiazoles
AU7961800A (en) Thiazolidinedione derivatives
SI1173434T1 (en) Thiazolidinedione derivative and its use as antidiabetic
HK1058192A1 (en) A thiazolidinedione derivative and its use as antidiabetic
HUP0201308A2 (en) Imidazo-containing heterocyclic compounds, their compositions and uses
SI1231211T1 (en) Thiazolidinedione derivatives as antidiabetic agents
SI1325000T1 (sl) Derivat tiazolidindiona in njegova uporaba kot antidiabetik
HRP20020971A2 (en) 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors
ZA200204266B (en) Arylamine derivatives and their use as anti-telomerase agent.